These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32116191)

  • 1. Single Heterocyclic Compounds as Monoamine Oxidase Inhibitors: From Past to Present.
    Wu SM; Qiu XY; Liu SJ; Sun J
    Mini Rev Med Chem; 2020; 20(10):908-920. PubMed ID: 32116191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease management. Part II- discovery of MAO-B inhibitors based on nitrogen heterocycles and analogues.
    Reis J; Encarnação I; Gaspar A; Morales A; Milhazes N; Borges F
    Curr Top Med Chem; 2012; 12(20):2116-30. PubMed ID: 23231391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and selective human monoamine oxidase B inhibition of heterocyclic hybrids based on hydrazine and thiazole scaffolds.
    Carradori S; D'Ascenzio M; De Monte C; Secci D; Yáñez M
    Arch Pharm (Weinheim); 2013 Jan; 346(1):17-22. PubMed ID: 23065686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoamine oxidase inhibitory effects of pentanthrene type heterocyclic compounds].
    Noda A; Noda H; Imamura T; Ono Y; Morita M; Kai M; Mine S; Goto S
    Yakugaku Zasshi; 1991 Sep; 111(9):499-503. PubMed ID: 1762051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SENSITIVITY OF LIVER MONOAMINE OXIDASE IN THE LAMPREY LAMPETRA FLUVIATILIS TO SOME TRICYCLIC COMPOUNDS].
    Basova LN; Basova NE; Suvorov AA; Yagodina OV
    Zh Evol Biokhim Fiziol; 2015; 51(3):163-9. PubMed ID: 26281218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
    Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
    Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantum chemical modeling of the inhibition mechanism of monoamine oxidase by oxazolidinone and analogous heterocyclic compounds.
    Erdem SS; Özpınar GA; Boz Ü
    J Enzyme Inhib Med Chem; 2014 Feb; 29(1):81-6. PubMed ID: 23323992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of synthetic indole derivatives as inhibitors of monoamine oxidase.
    Chirkova ZV; Kabanova MV; Filimonov SI; Abramov IG; Petzer A; Petzer JP; Suponitsky KY
    Bioorg Med Chem Lett; 2016 May; 26(9):2214-9. PubMed ID: 27020523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
    Nel MS; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the monoamine oxidase inhibition properties of pyrrolo[3,4-f]indole-5,7-dione and indole-5,6-dicarbonitrile derivatives.
    Chirkova ZV; Kabanova MV; Filimonov SI; Abramov IG; Petzer A; Engelbrecht I; Petzer JP; Yu Suponitsky K; Veselovsky AV
    Drug Dev Res; 2018 Mar; 79(2):81-93. PubMed ID: 29570223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
    Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
    Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase inhibitory activities of heterocyclic chalcones.
    Minders C; Petzer JP; Petzer A; Lourens AC
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5270-6. PubMed ID: 26432037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistry.
    Cagide F; Silva T; Reis J; Gaspar A; Borges F; Gomes LR; Low JN
    Chem Commun (Camb); 2015 Feb; 51(14):2832-5. PubMed ID: 25579652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological properties of dihydro-oxadiazine-based heterocyclic derivatives.
    Ke S; Cao X; Liang Y; Wang K; Yang Z
    Mini Rev Med Chem; 2011 Jul; 11(8):642-57. PubMed ID: 21651466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Natural Products of Herbal Origin as Monoamine Oxidase Inhibitors.
    Orhan IE
    Curr Pharm Des; 2016; 22(3):268-76. PubMed ID: 26561069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibitors of monoamine oxidase (MAO). 5. 1-Substituted phenoxathiin inhibitors containing no nitrogen that inhibit MAO A by binding it to a hydrophobic site.
    Harfenist M; McGee DP; Reeves MD; White HL
    J Med Chem; 1998 Jun; 41(12):2118-25. PubMed ID: 9622553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel monoamine oxidase selective inhibitors employing a hierarchical ligand-based virtual screening strategy.
    Wang D; Li Z; Liu Y; Chen M; Chen N; Zuo Z; Kong DX
    Future Med Chem; 2019 Apr; 11(8):801-816. PubMed ID: 31140884
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
    Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors.
    Pisani L; Barletta M; Soto-Otero R; Nicolotti O; Mendez-Alvarez E; Catto M; Introcaso A; Stefanachi A; Cellamare S; Altomare C; Carotti A
    J Med Chem; 2013 Mar; 56(6):2651-64. PubMed ID: 23437843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.